search Created with Sketch.

July/August 2020

In This Issue

Associate Medical Editor’s Page

Streamlining the System

Arsham Sheybani, MD

The Literature

Screening and Identification of Patients With COVID-19

When is conjunctival transmission a concern, and how do asymptomatic carriers affect disease transmission?

S. Asha Balakrishnan, MD

Peer Review

Home-Based Glaucoma Monitoring

Tools for expanding glaucoma diagnosis and management beyond the office.

Kateki Vinod, MD, and Sarwat Salim, MD, FACS

Global Perspectives

Glaucoma and COVID-19

Despite initial delays in patient care, glaucoma treatment in Wuhan has returned to normal.

Tu Haixia, MD, and Wang Yong, MD

Case Files

The Highest IOP I Ever Measured

Which type of surgical intervention is most appropriate?

Devesh K. Varma, MD, FRCSC; Steven J. Gedde, MD; Joseph F. Panarelli, MD; and Oluwatosin Smith, MD

Therapeutics Update

Cannabis and Glaucoma

The importance of strain and chemical composition.

Ahmad A. Aref, MD, MBA



Virtual options can almost always be offered to patients with neuro-ophthalmologic conditions.

Kevin E. Lai, MD; Devin D. Mackay, MD; and Melissa W. Ko, MD

Residents & Fellows

A Disease of Paradoxes

Reflections on the ups and downs of addressing glaucoma.

Amol Sura, MD, and Albert S. Khouri, MD

Cover Focus

From Drops to Drug Delivery: Changing the Hearts and Minds of Clinicians

What factors influence a lasting evolution in care?

Jason Bacharach, MD

Cover Focus

Sustained Drug Delivery: Real-World Experience

Surgeons describe their initial cases and the insights gained using a new pharmaceutical solution for glaucoma.

Gagan Sawhney, MD; Roman Krivochenitser, MD; Blake K. Williamson, MD, MPH; and Steven R. Sarkisian Jr, MD

Cover Focus

Implementing Advances in Drug Delivery

How do new treatment options fit in with existing therapeutic strategies?

I. Paul Singh, MD

Cover Focus

In the Pipeline

New therapeutics and drug delivery systems are in the works.


The Buzz on

Seen & Heard

Seen & Heard